EPS

(redirected from Electrophysiologic study)
Also found in: Dictionary, Medical, Financial, Wikipedia.
Related to Electrophysiologic study: Cardiac electrophysiology, Electrophysiology Study of the Heart

EPS

EPS

(1) (Evolved Packet System) See LTE.

(2) (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. Adobe Illustrator has its own variation of EPS, which is an EPS subset, thus, both Illustrator EPS and standard EPS files are in use.

From Drawing Program to Page Layout Program
A typical usage of EPS is to save an illustration created in a drawing program as an EPS file and to import it into a page layout program such as InDesign or QuarkXPress. The layout artist would place and resize the image, which would either be the embedded preview or rendered directly from the PostScript code. The EPS images would be saved in the page layout program. See PostScript.
References in periodicals archive ?
Individuals with asymptomatic BRS with a family history of SCD should be examined for mutations of the SCN5A gene and possible electrophysiologic study (EPS).
These include over 10 national trials with the National Heart, Lung, and Blood Institute (NHLBI) including the Beta Blocker Heart Attack Trial (BHAT), the Cardiac Arrhythmia Pilot Study (CAPS), Thrombolysis in Myocardial Infarction (TIMI I, II), Studies of Left Ventricular Dysfunction (SOLVD), Comparison of Electrophysiologic Study to Electrocardiographic Monitoring (ESVEM), Cardiac Arrhythmia Suppression Trial (CAST), Asymptomatic Cardiac Ischemia Pilot (ACIP), Antiarrhythmic Drugs Versus Defibrillators (AVID) and the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trials.
The patient in Case 2 was initially scheduled for an electrophysiologic study, but his motor deficit recovered rapidly, so no further investigations were arranged.
In 1996, Moss et al (12) reported the results of the MADIT I trial and recommended ICDs in all patients with nonsustained VT and inducible nonsuppressible VT at electrophysiologic study.
A Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Tecadenoson in Patients with PSVT Undergoing an Electrophysiologic Study: TEMPEST (Trial to Evaluate the Management of PSVT during Electrophysiologic Study with Tecadenoson).